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Abstract: Primary Biliary Cholangitis (PBC) is an autoimmune cholestatic liver disease linked to symp-
toms including fatigue and altered mood/cognition, indicating that chronic liver inflammation associated
with PBC can impact brain function. We employed near infrared spectroscopy (NIRS), a non-invasive
neuroimaging technique, to determine whether PBC patients exhibit reduced cerebral oxygen saturation
(StO2) and altered patterns of microvascular cerebral blood perfusion, and whether these alterations
were associated with clinical phenotype. This observational case-control study was conducted at a ter-
tiary hospital clinic (University of Calgary Liver Unit). Thirteen females with non-cirrhotic PBC, seven
females with cirrhotic PBC, and eleven healthy female controls were recruited via physician referral and
word of mouth, respectively. Near infrared spectroscopy was used to measure cerebral hemoglobin and
oxygen saturation. A wavelet phase coherence method was used to estimate the coherent frequency cou-
pling of temporal changes in cerebral hemodynamics. The PBC group demonstrated significantly reduced
cerebral StO2 (p = 0.01, d = 0.84), indicating cerebral hypoxia, significantly increased cerebral deoxy-
hemoglobin (HHb) concentration (p < 0.01, d = 0.86), and significantly reduced hemodynamic coherence
in the low-frequency band (0.08-0.15 Hz) for oxygenated hemoglobin (O2Hb) concentration (p = 0.02, d
= 0.99) and tHb concentration (p = 0.02, d = 0.50), indicating alterations in cerebrovascular activity.
Complete biochemical response to ursodexycholic acid (UDCA) therapy in early PBC patients was as-
sociated with increased cerebral tHb concentration and decreased hemodynamic coherence. Conclusion:
Using NIRS, PBC patients were found to have hypoxia, increased cerebral hemoglobin concentration, and
altered cerebrovascular activity, that were reversed in part in UDCA responders. In addition, symptoms
and quality of life measures did not correlate with brain hypoxia or cerebrovascular dysregulation in PBC
patients.
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Primary Biliary Cholangitis (PBC) is an autoimmune cholestatic liver disease linked to 
symptoms including fatigue and altered mood/cognition, indicating that chronic liver 
inflammation associated with PBC can impact brain function. We employed near 
infrared spectroscopy (NIRS), a non-invasive neuroimaging technique, to determine 
whether PBC patients exhibit reduced cerebral oxygen saturation (StO2) and altered 
patterns of microvascular cerebral blood perfusion, and whether these alterations 
were associated with clinical phenotype. This observational case-control study was 
conducted at a tertiary hospital clinic (University of Calgary Liver Unit). Thirteen 
females with non-cirrhotic PBC, seven females with cirrhotic PBC, and eleven healthy 
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Near infrared spectroscopy was used to measure cerebral hemoglobin and oxygen 
saturation. A wavelet phase coherence method was used to estimate the coherent 
frequency coupling of temporal changes in cerebral hemodynamics. The PBC group 
demonstrated significantly reduced cerebral StO2 (p = 0.01, d = 0.84), indicating 
cerebral hypoxia, significantly increased cerebral deoxy-hemoglobin (HHb) 
concentration (p < 0.01, d = 0.86), and significantly reduced hemodynamic coherence 
in the low-frequency band (0.08-0.15 Hz) for oxygenated hemoglobin (O2Hb) 
concentration (p = 0.02, d = 0.99) and tHb concentration (p = 0.02, d = 0.50), indicating 
alterations in cerebrovascular activity. Complete biochemical response to 
ursodexycholic acid (UDCA) therapy in early PBC patients was associated with 
increased cerebral tHb concentration and decreased hemodynamic coherence. 
Conclusion: Using NIRS, PBC patients were found to have hypoxia, increased 
cerebral hemoglobin concentration, and altered cerebrovascular activity, that were 
reversed in part in UDCA responders. In addition, symptoms and quality of life 
measures did not correlate with brain hypoxia or cerebrovascular dysregulation in 
PBC patients. 
Primary Biliary Cholangitis (PBC) is an autoimmune cholestatic liver disease characterized 
by the immunological destruction of small hepatic bile ducts and chronic liver inflammation 
(1). PBC can progress to cirrhosis after many years; however, treatment with the bile acid 
ursodeoxycholic acid (UDCA) prevents disease progression in those who respond to therapy 
(1). Although prevalence estimates vary geographically, a recent US study reports a PBC 
prevalence of 4.3 per 100,000 in women and 1.1 per 100,000 in men, and similar findings 
have been reported in Canada (2). PBC is commonly associated with a number of 
behavioral symptoms including fatigue, itch, altered mood and cognitive changes, indicating 
that PBC can alter brain function (1, 3). However, the mechanism whereby PBC can impact 
brain function remains unknown. Importantly, PBC-associated symptoms often do not 
correlate with severity of liver disease, biochemical response to therapy, or changes in brain 
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Therefore, an improved understanding of how brain changes occur in association with PBC, 
and their potential role in symptom development, is of significant importance to improve 
management of these patients.    
Tight regulation of cerebral blood flow is critical to ensure normal brain oxygenation and 
function. Cerebrovascular dysfunction and hypoxia have been implicated in a range of 
neurodegenerative and neuroinflammatory disorders including Alzheimer’s disease and 
multiple sclerosis (MS) (5, 6). We have shown, using functional MRI (fMRI), that PBC 
patients exhibit alterations in functional hyperemia (7), although it remains difficult to 
determine whether alterations in functional hyperemia arise solely from altered brain activity, 
or whether cerebrovascular dysfunction plays a role (8).
Near infrared spectroscopy (NIRS) allows for non-invasive measurement of oxygenated 
(O2Hb) and deoxygenated hemoglobin (HHb) concentration in cortical brain tissue (9). 
Therefore, NIRS can be used to quantify cortical tissue oxygen saturation (StO2), which 
reflects changing metabolic rate and perfusion (10). Furthermore, functional NIRS (fNIRS) 
can be used to probe brain activity in a similar fashion to fMRI, by assuming that the 
measured changes in blood perfusion and oxygenation are due to functional hyperemia, i.e. 
hemodynamic changes caused by neural activity (11). It is important, however, to note that 
due to the biophysical properties of light transmission in tissue, NIRS is limited to 
approximately 3 cm depth penetration, and is therefore unable to measure deep brain 
structures. Using NIRS in patients, altered patterns of brain blood perfusion and reduced 
brain oxygenation levels have been previously shown to correlate with fatigue (12) and 
impaired cognition (13, 14), linking reduced cortical perfusion to symptoms that have been 
reported to occur in PBC patients. Considering this link in the context of neuroinflammation 
associated with chronic peripheral inflammation, PBC-related alterations in cortical perfusion 
and oxygenation may contribute, at least in part, to the behavioral symptoms associated with 
PBC. Therefore, we undertook the following series of experiments using NIRS to determine 
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microvascular cerebral blood perfusion, and whether NIRS findings of oxygen saturation and 
perfusion correlate with clinical disease markers, as well as symptom and quality of life 
scores in PBC patients.
Patients and Methods
Human Subjects. Thirteen females (median age 61 years; range 39-77 years) with non-
cirrhotic (defined by serum biochemistry and Fibroscan® (15) scores) PBC and seven 
females with cirrhotic PBC (median age 59 years; range 49-65) were recruited from the 
University of Calgary Liver Unit. Eleven healthy female controls (median age 58 years; range 
42-61 years) were recruited from the community via word of mouth. All patients were anti-
mitochondrial antibody (AMA) positive. Written informed consent was obtained for all 
subjects prior to participation in the study. This study was approved by the University of 
Calgary human research ethics committee and conforms to the ethical guidelines of the 
1975 Declaration of Helsinki. Clinical markers of disease activity and severity (Fibroscan®, 
disease duration, and serum markers alkaline phosphatase (ALP), alanine aminotransferase 
(ALT), gamma-glutamyl transferase (GGT), immunoglobulin M (IgM), and hemoglobin (Hgb)) 
and treatment response to UDCA were recorded at the time of study participation for all PBC 
patients. Complete response to UDCA therapy was defined as the normalization of serum 
ALP after starting UDCA treatment. See Table 1 for patient’s clinical data. 
Questionnaires
All PBC subjects completed a general quality of life questionnaire (PROMIS–29) (16), a 
disease-specific quality of life questionnaire (PBC–40) (17), a cognitive impairment test (6–
CIT) (18), and an anxiety and depression questionnaire (HADS) (19), immediately prior to 
NIRS testing. See appendix Table 1 in the supplementary material.
Measurement of Resting-State Hemodynamic Coherence
A TechEn NIRSOptix continuous-wave functional NIRS (fNIRS) system was used to record 
changes in cerebral oxygenation, at a sampling rate of 25 Hz. A custom 44-channel head-
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(Fig. 1). Light-emitting lasers transmit light at two discrete wavelengths (690 nm and 830 
nm), while photodetectors continuously receive the light as it exits the tissue, producing a 
continuous recording of local changes in O2Hb and HHb concentration in the cerebral cortex 
(9). Participants were seated in a darkened room and asked to breathe normally, limit 
movement, and maintain focus on a white fixation cross on a black monitor, while fNIRS 
data were continuously recorded for seven minutes. 
 
We utilized a wavelet phase coherence method to calculate the synchrony of spontaneous 
hemodynamic oscillations across a range of frequency scales that arise from auto-regulatory 
processes as well as neurovascular coupling. This method has previously been applied in 
fNIRS and functional MRI studies to evaluate patterns of synchronous hemodynamic activity, 
sometimes referred to as functional connectivity (20, 21). 
Pairwise (channel-to-channel) coherence for each subject was calculated for two frequency 
bands. The first frequency band consisted of low-frequency (LF: 0.08 - 0.15 Hz) oscillations 
often referred to as Mayer waves, which are thought to arise from the sympathetic regulation 
of blood pressure dynamics via modulation of vasomotor activity (22). The second frequency 
band consisted of very low-frequency (VLF: 0.01 - 0.08 Hz) oscillations, which are thought to 
be associated with neurovascular coupling in the cerebral cortex (i.e. functional connectivity) 
(23), but can also be affected by changes in systemic physiology such as breathing (24) and 
the arterial partial pressure of carbon dioxide (25). For each subject, a single global 
coherence value was determined by averaging all channel pair coherence values. See 
supplementary material for a schematic of the fNIRS analysis pipeline.
Quantification of Absolute Hemoglobin and Oxygen Saturation
An ISS Oxiplex (frequency-domain near infrared spectroscopy) was used to quantify 
absolute O2Hb, HHb, and total hemoglobin (tHb; ie. O2Hb + HHb) concentrations, as well as 
to calculate StO2 (ie. O2Hb/tHb) (26). A single probe was held over bilateral prefrontal 
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above the eyebrow, to avoid the frontal sinus. All data were visually inspected and large 
spikes, which can be due to momentary uncoupling of the probe to the skin, were removed. 
Bilateral recordings were then averaged to produce one value for each parameter, per 
subject. 
Group-level Statistical Analysis
Statistical comparison demonstrated that the cirrhotic PBC patients were similar to the non-
cirrhotic PBC patients in terms of NIRS parameters. Therefore, all PBC patients were 
combined into one group for subsequent group analyses. The PBC patient group was 
compared to the control group for StO2, hemoglobin concentration (O2Hb, HHb, tHb), and 
coherence (O2Hb, HHb, tHb). A non-parametric Wilcoxon rank-sum test (27) was used to 
test whether PBC patients differed from controls, for all NIRS parameters. Cohen’s d, which 
is defined as the mean group difference divided by the pooled standard deviation of the data 
(28), was used to evaluate the magnitude of the effect in PBC patients compared to normal 
controls for all NIRS parameters. An effect size of d = 0.2 is considered ‘small’, whereas d = 
0.5 is considered a ‘medium’ effect, and d = 0.8 is considered a ‘large’ effect (28).
Associations with Clinical Phenotype
Robust regression analysis was used to explore the relationship between NIRS markers of 
oxygen saturation, hemoglobin concentration, and coherence, and to investigate whether 
NIRS markers were associated with disease-specific and quality of life questionnaire scores. 
To determine whether NIRS markers were sensitive to treatment response in early PBC (as 
reflected by ALP normalization following UDCA treatment), the non-cirrhotic PBC patients 
were split into two groups, normal ALP (<145 U/L) and high ALP (>145 U/L). Wilcoxon rank-
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The PBC group had significantly reduced low-frequency (LF) (0.08 - 0.15 Hz) coherence for 
O2Hb (Fig. 2; Control: 0.59  0.06 vs PBC: 0.54  0.04, mean  SD, p = 0.02, d = 0.99) and 
tHb (Fig. 2; Control: 0.61  0.06 vs PBC: 0.55  0.04, mean  SD, p = 0.02, d = 1.40) 
parameters, but not for HHb (Fig. 2; Control: 0.50  0.06 vs PBC: 0.49  0.01, mean  SD, p 
= 0.25, d = 0.24). The difference between PBC group and controls for very low-frequency 
(VLF) (0.01 - 0.08 Hz) coherence approached, but did not reach significance (O2Hb - 
Control: 0.61  0.04 vs PBC: 0.59  0.03, mean  SD, p = 0.21, d = 0.50; HHb - Control: 
0.56  0.03 vs PBC: 0.55  0.02, mean  SD, p = 0.77, d = 0.14; tHb -  Control: 0.62  0.04 
vs PBC: 0.60  0.04, mean  SD, p = 0.06, d = 0.82). Two PBC patients were excluded from 
this analysis due to insufficient signal quality. 
Absolute Hemoglobin Concentration and Oxygen Saturation
Absolute StO2 was found to be significantly reduced in the PBC group, compared to healthy 
controls (Fig. 3; Control: 61.60%  7.12 vs PBC: 55.32%  4.26, mean  SD, p = 0.01, d = 
0.84). The PBC group also had increased deoxyhemoglobin concentration (HHb) (Fig. 3; 
Control: 14.70 μM  5.19 vs PBC: 20.10 μM  5.91, mean  SD, p < 0.01, d = 0.86), 
compared to healthy controls. PBC patients did not significantly differ from controls for 
oxyhemoglobin or total hemoglobin concentrations. Three PBC patients were found to have 
inadequate signal quality due to poor optode coupling and/or technical complications, and 
were excluded from this analysis.
Associations between NIRS and Clinical Phenotype
NIRS markers were not significantly associated with any of the symptom or quality of life 
scores. To explore whether NIRS measures were sensitive to biochemical markers of 
disease status and treatment response in early PBC, non-cirrhotic PBC patients were 
grouped into normal (indicating UDCA therapy responders) and abnormal (indicating UDCA 
therapy non-responders and/or treatment refusal). Patients who either did not respond to 
treatment (n = 4) or refused treatment (n = 1) had significantly reduced very-low frequency 










This article is protected by copyright. All rights reserved
concentration (n.s., p = 0.17), but no difference in oxygen saturation, compared to patients 
who responded to UCDA treatment (n = 8) (Fig.4). As expected, the non-responders 
(elevated ALP) also had elevated levels of GGT and ALT, which are markers of liver injury.
Discussion
It is well-established that peripheral immune activation via systemic administration of 
cytokines (e.g. tumor necrosis factor α [TNFα], interleukin-6, interleukin-1) or endotoxin (e.g. 
lipopolysaccharide) can induce neuroinflammation, alter brain function, and cause 
behavioral changes in mammals (29). These findings have led many to hypothesize that 
immune activation occurring within the body can have a deleterious effect on the brain, 
directly contributing to the development of behavioral changes commonly associated with a 
number of chronic immune-mediated diseases, including PBC. Although, the underlying 
mechanism whereby chronic immune activation in peripheral tissue compartments can 
induce changes in brain function, linked to disease-associated symptoms, remains poorly 
understood.
Adequate delivery of oxygen and glucose, needed to meet the metabolic demands of brain 
tissue, is critically important for proper brain health and function (11). This balance is 
achieved through highly sensitive mechanisms of blood flow regulation such as 
neurovascular coupling (NVC), cerebrovascular reactivity, and cerebral autoregulation. NVC 
is characterized by a robust increase in local blood flow in response to neuronal activity, 
referred to as functional hyperemia. NVC is primarily mediated through vasoactive signaling 
molecules such as arachidonic acid, and nitric oxide, as well as K+ and pH, and relies on the 
intricate interplay between cerebral endothelial cells (CEC), glial cells, pericytes, vascular 
smooth muscle cells, and neurons (11). Functional hyperemia forms the basis of the blood 
oxygen level-dependent (i.e. BOLD) signal in functional MRI, and the oxygenated (O2Hb) 
and deoxygenated (HHb) hemoglobin signal in fNIRS, which are commonly used as indirect 
measures of local brain activity. Using NIRS, reduced task-induced O2Hb and HHb response 
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impairment (14). Of particular interest, using NIRS, one group reported decreased frontal 
lobe oxygenation during a verbal fluency task in patients with ulcerative colitis as well as in 
patients with non-alcoholic fatty liver disease, but not in patients with Crohn’s disease (31, 
32). The authors attributed these findings to altered brain activity, although it is difficult to 
delineate altered brain activity from altered neurovascular coupling in patients with potential 
cerebrovascular dysfunction (8).
To gain a greater understanding of how chronic immune-mediated liver inflammation 
impacts the brain of patients with PBC, we applied a novel time-frequency (coherence) 
analysis in conjunction with quantitative measures of hemoglobin concentration and oxygen 
saturation. This analysis allowed us to probe patterns of hemodynamic activity at varying 
frequencies, in an effort to try and differentiate alterations in cerebrovascular function from 
alterations in neuronal activity. Further, quantification of hemoglobin concentrations and 
oxygen saturation provide insight into whether PBC patients have altered metabolism and/or 
are hypoxic.
Resting-State Hemodynamic Coherence
We found that PBC patients exhibit significantly reduced cortical hemodynamic coherence 
(Fig. 2), similar in magnitude to reductions we have previously reported in adults with MS (6) 
and in adults and children with chronic symptoms following mild traumatic brain injury (33, 
34). In particular, our findings of reduced coherence were greatest for frequencies centered 
around the ~0.1 Hz oscillation (10 second rhythm) known as the Mayer wave, indicating 
altered vasomotor regulation of cerebral blood flow (22). Dysregulation of cerebral blood flow 
and perfusion in these patients may result from two potential mechanisms: 1) disrupted 
efferent sympathetic nervous control of arterial blood pressure, and/or 2) direct damage or 
injury to the vascular endothelial cells, both of which may cause dysfunctional vasomotor 
activity. Previously, we have shown that following bile duct ligation in mice, liver 
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vessels (3), providing evidence of the latter as a potential driver of altered cerebral 
vasomotor regulation of cerebral blood flow found in patients with chronic liver inflammation. 
Healthy CECs are critically important for blood flow regulation, as well as the normal function 
of the blood-brain barrier (BBB). Cytokines (e.g. TNFα, interleukin-1, interleukin-6) 
originating from within the central nervous system, or present in the peripheral blood 
circulation, can induce CEC dysfunction and increase BBB permeability, which is known to 
be associated with many neurological disorders including Alzheimer’s (35), and MS (36), as 
well as peripherally induced neuroinflammation (3). Indeed, CECs exposed to the cytokines 
TNFα or interleukin-6 express fewer inter-endothelial proteins and have greater reactive 
oxygen species generation leading to increased BBB permeability (37). Furthermore, CECs 
can be activated by cytokines that are either present in the blood or released by circulating 
immune cells in intimate contact with CECs, to produce secondary signaling molecules (e.g. 
additional cytokines, prostaglandin E2, nitric oxide) which interact with cells within the brain 
to alter NVC responses (38, 39). Consistent with this suggestion, in a mouse model of 
cholestatic liver disease we have shown that activated monocytes within the cerebral 
circulation adhere to CECs and induce CEC activation via TNFα - TNF receptor-1 
interactions (40, 41). This immune cell and TNFα driven CEC activation upregulates CEC 
inducible nitric oxide synthase expression and is directly linked to activation of microglia 
within the brain (especially those cells in close proximity to blood vessels) (40), and 
ultimately to altered behaviors expressed by cholestatic mice (42, 43). These previous 
findings from our group provide a mechanism by which peripheral inflammation can impact 
the function of CECs, thereby altering cerebrovascular function.
The existence of endothelial signaling pathways to neurons and astrocytes have increasingly 
been recognized as key regulators of NVC within the brain (11). In MS patients, similar to 
our findings in cholestatic mice, blocking activated immune cells within the circulation from 
adhering to CECs increases task-induced cortical blood flow (ie. NVC) (44), suggesting that 
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play an essential role in the regulation of cerebral blood flow by passively allowing vessel 
smooth muscle to relax and contract. Interestingly, activated leukocytes have been shown to 
promote endothelial-dependent vasospasticity and reduce arterial relaxation in vitro and in 
vivo (38). Further, endothelial-dependent vasospasticity is heightened in the presence of 
protein aggregates in the blood (38), which would effectively reduce the dynamic range of 
vasodilation. This is particularly interesting considering our previous findings that cholestatic 
liver injury leads to increased CEC presentation of the adhesion molecule P-selectin, which 
in turn promotes leukocyte and platelet adhesion to CECs (42, 43). Taken together, these 
findings suggest that increased leukocyte-CEC interactions associated with peripheral 
inflammation may significantly contribute to altered cerebrovascular dynamics and potential 
neurovascular uncoupling in PBC patients.
The second potential contributor to altered cerebrovascular activity in these patients is 
dysfunctional sympathetic control of the vasomotor activity that generates Mayer wave 
oscillations (~0.1 Hz). Under normal conditions in healthy individuals, arterial pressure is 
highly correlated with sympathetic nervous activity at the ~0.1 Hz frequency, indicating that 
autonomic control of vasodilation and vasoconstriction is essential for generating the Mayer 
wave (~0.1 Hz oscillation) (22). Using various methods (i.e. measuring physiological 
responses such as heart rate, blood pressure, and blood volume to physiological stressors 
such as the Valsalva maneuver, deep breathing, and sitting-to-standing) autonomic 
dysfunction in PBC patients has been reported by several groups, perhaps most notably in a 
study by Newton and colleagues (45). Interestingly, the authors found autonomic dysfunction 
to be associated with both cognitive impairment and frontal cortex legion load on structural 
MRI images of PBC patients (45). This finding links autonomic dysfunction in PBC patients 
to altered brain structure and function in the frontal brain region of PBC patients, supporting 
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Some evidence suggests that reduced cerebral oxygenation and vasomotor activity may 
occur in the context of healthy aging (47, 48). In our study, all three groups had comparable 
mean and median age, however the PBC cohort had a wider age-range than the control and 
cirrhotic groups. One PBC patient in particular was well above the age distribution of the 
controls (Patient ID 002; 77 years of age). This patient was unremarkable in terms of 
hemodynamic coherence and cerebral oxygenation, suggesting that age did not impact our 
findings. However further studies could address the impact of age more formally to 
determine any potential effect of age on cerebral hemodynamics in this population.
Cortical Oxygen Saturation and Hemoglobin Concentration
We have identified a striking reduction in cortical tissue oxygen saturation (StO2) levels in 
the frontal cortex of some PBC patients at rest (Fig. 3); similar in magnitude to levels 
previously reported by us in the frontal cortices of patients suffering with the 
neuroinflammatory disease MS (6). In the setting of increased platelet-immune-CEC 
interactions and altered vessel dynamics discussed above, we propose that hypoxia results 
from a physical reduction in blood flow through the brain microvasculature, coupled with a 
local increase in metabolic activity (due to heightened local immune cell activity). In support 
of this hypothesis, we observed a significant (p < 0.01, d = 0.86) increase in deoxygenated 
cerebral hemoglobin in the PBC patients, without a change in total hemoglobin, suggesting 
that local cerebral metabolic rate of oxygen has increased without a corresponding increase 
in perfusion, leading to hypoxia in these patients. 
In addition, hypoxia and inflammation may in fact create a positive feedback loop, which has 
previously been hypothesized to play an important role in MS disease progression (46). In 
the proposed hypoxia-inflammation cycle, hypoxia inhibits the enzyme prolylhydroxylase 
allowing for the activation of nuclear factor kappa B and hypoxia inducible factor-1 alpha, 
and subsequently the up-regulation of pro-inflammatory cytokines and leukocyte infiltration. 
In addition, activation of the hypoxia inducible factor-1 alpha pathway is known to selectively 
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observed in some PBC patients may create a hypoxia-inflammation cycle that contributes to 
cerebrovascular dysfunction and further exacerbates hypoxia.  
Association with Clinical Phenotype
In this study, abnormal cortical oxygenation and coherence in PBC patients were not 
significantly associated with symptom or quality of life measures, which may be explained by 
several factors. First, as previously discussed in the American Association for the Study of 
Liver Diseases 2018 practice guidelines, symptoms and stage of disease are not strongly 
correlated in PBC patients (1), indicating that symptom questionnaires are not an accurate 
marker of liver disease severity. It is also important to consider the overall level of symptom 
burden in this particular cohort. Based on prior classifications of the PBC-40 symptom 
inventory (50), a majority of the PBC patients in this cohort reported mild-moderate symptom 
burden, and only three patients (all cirrhotic) reported severe burden in any of the symptom 
categories. Finally, it is also possible that the abnormal markers of oxygenation and 
cerebrovascular activity measured here in PBC patients preclude more overt changes in 
behavior and function in advanced disease. 
There is, however, an apparent association between NIRS markers and biochemical 
markers of response to therapy in early PBC (non-cirrhotic) patients. Specifically, to 
determine if NIRS is sensitive to treatment response in early PBC, we explored the 
relationship between serum ALP levels and NIRS markers of oxygen saturation, hemoglobin 
concentration, and cortical coherence in non-cirrhotic PBC patients. Elevated ALP is an 
important biomarker for PBC diagnosis and prognosis, and normalization of ALP is 
considered a clinical marker of complete treatment response to UDCA. In our non-cirrhotic 
cohort, we found that the group of patients who did not have a normal ALP level (indicating 
non-response to UDCA, n = 4; or treatment refusal, n = 1) demonstrated reduced coherence 
for the very low frequency band. Cerebral hemoglobin concentrations appeared to be 
increased in those patients with abnormal ALP, although there was no significant difference 
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surprisingly, an extreme outlier for high ALP (415 U/L). Interestingly, this patient was also an 
outlier for cerebral hemoglobin concentration (tHb: 69 μM, O2Hb: 41 μM, and HHb: 28 μM) 
and had relatively low coherence for both frequency bands (LF = 0.53, VLF = 0.59) 
compared to the control distribution. These findings suggest cerebral hemoglobin 
concentration and altered cerebrovascular activity may be biomarkers of PBC, and that 
improved bile flow and decreased liver inflammation, in patients who respond to UDCA 
therapy, may protect against deleterious brain changes associated with PBC. However, 
similar to widely reported clinical experience, improvements in serum ALP levels with UDCA 
therapy do not appear to improve PBC-associated behavioral symptoms. Moreover, our 
findings of UDCA-induced normalization of brain hemoglobin concentration and low-
frequency coherence support the potential of using NIRS technology in future studies to 
evaluate disease progression and treatment response in early PBC patients. 
Conclusion
Through clinical and preclinical observations, it is increasingly apparent that there is a link 
between peripheral inflammation, alterations in brain function, and sickness behavior 
development. However, the underlying pathogenic driver(s) of these brain changes are not 
well understood. In this study, we report the existence of cerebrovascular dysfunction, 
hypoxia, and increased hemoglobin concentration in patients suffering from the chronic 
immune-mediated inflammatory liver disease PBC. Interestingly, these alterations were not 
associated with symptom or quality of life changes in these patients, however, they were 
associated with abnormally high serum ALP in early PBC patients, suggesting that UDCA 
treatment response either slows or reverses brain changes associated with PBC, and that 
NIRS markers are sensitive to treatment response. Our findings support the potential use of 
the portable and non-invasive near infrared spectroscopy device as a useful neuroimaging 
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Table 1: Patient demographics and clinical data. Patient data was compiled from review 
of clinical charts. UDCA treatment response is defined as normalization of serum ALP 
levels after starting UDCA treatment. Cirrhotic patients are shaded grey. Cirrhosis is 
defined by a Fibroscan > 16.9 kPa in PBC. Serum ALP, ALT, GGT, IgM, and Hgb levels 
were measured by Calgary Laboratory Services. UDCA = Ursodeoxycholic acid; ALP = 
Alkaline Phosphatase; ALT = Alanine Aminotransferase; GGT = Gamma-glutamyl 


















(N 11- 63) 
IgM (g/L) 




Hgb (g/L)  
(N 120-160) 
001 39 Y 5.1 79 36 53 1.76 5 138 
002 77 Y 4.5 93 14 18 5.10 10 135 
003 59 N 14.0 166 69 311 5.51 18 148 
004 62 Y 5.7 85 9 37 7.25 3 131 
005 67 Y 11.4 80 41 41 3.34 15 132 
006 62 N 6.3 148 71 147 2.94 5 141 
007 52 Y 3.5 85 30 107 3.10 1 145 
008 66 N 5.6 157 26 70 2.10 9 135 
009 62 Y 5.1 97 43 135 0.70 15 122 
010 41 Y 6.6 104 28 114 3.14 3 126 
011 61 n/a 10.7 415 66 507 4.75 9 143 
012 55 N 6.0 204 43 172 4.27 1.5 148 
013 54 Y 6.6 128 40 55 2.41 3.4 139 
014 57 Y 17.3 135 37 44 1.7 8 89 
015 65 N 35.9 169 30 49 1.03 28 125 
016 49 N n/a 228 48 92 6.17 2 119 
017 62 Y 23.8 141 41 83 n/a 10 129 
018 59 n/a 33.2 118 17 23 5.04 17 101 
019 62 N 33 355 50 212 2.02 4.5 129 











This article is protected by copyright. All rights reserved 
 
 p value Effect size 
(Cohen’s d) 
Quantification of tissue hemoglobin 
concentration and oxygen 
saturation 
O2Hb 0.37 0.49 
HHb **0.00 0.86 
tHb 0.17 0.83 
StO2 *0.01 0.84 
Low-frequency coherence 
0.08 – 0.15 Hz 
O2Hb *0.02 0.99 
HHb 0.25 0.24 
tHb *0.02 1.40 
Very low-frequency coherence 
0.01 – 0.08 Hz 
O2Hb 0.21 0.50 
HHb 0.77 0.14 
tHb 0.06 0.82 
Table. 2. Statistical values for group comparison of NIRS markers. Statistical 
results of Controls vs. PBC for each NIRS parameter. A Wilcoxon Rank-Sum test was 
used to evaluate significance (p-value) between PBC and control groups, for each 
parameter. Cohen’s d was used to calculate the size of the effect when comparing the 
PBC group to the control group. * p < 0.05, **p < 0.01; small effect is d = 0.2, medium 
effect is d = 0.5, large effect is d = 0.8. StO2 = oxygen saturation, tHb = total 
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